Michael Hoey
7 Papers
84 Citations
Michael Hoey is an academic researcher. The author has contributed to research in topics: Induction coil & Prostate cancer. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
Patent
Systems and methods for prostate treatment
Michael Hoey,Mark Schrom,Stephanos Paulos,Randall Beyreis +3 more
- 25 Mar 2011
TL;DR: A vapor delivery needle is provided in this paper that can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, and denaturate the prostate.
47
Patent
Induction coil vapor generator
Michael Hoey,Stephanos Paulos,Roger Noel Hastings +2 more
- 03 Apr 2013
TL;DR: In this paper, an induction coil vapor generator is presented that may include any of a number of features, such as the ability to generate high quality condensable vapor, which can be used in a medical device to treat tissue with vapor.
17
Patent
Systems and methods for treating the prostate
Michael Hoey,Roger Noel Hastings +1 more
- 10 Dec 2014
TL;DR: In this paper, a vapor delivery system and method for treating prostate tissue is described, which includes a needle configured to deliver condensable vapor energy to the prostate tissue, and the system is properly positioned based on a field-of-view of an endoscope or camera disposed within the system.
9
Patent
Vapor ablation systems and methods
Roger Noel Hastings,Michael Hoey,Steven Carlson,Matthew Byrne +3 more
- 10 Dec 2014
TL;DR: In this article, a vapor delivery system and method is provided that includes a number of features, such as insertion of a needle into tissue of a patient, activating a flow of vapor from a vapor generator through vapor delivery ports of the vapor delivery needle to cause condensed liquid to exit vapor delivery points of the needle.
8
Patent
Systems and methods for treating prostate cancer
Michael Hoey,Grant Mauch,Mark Schrom +2 more
- 14 Mar 2014
TL;DR: In this paper, a vapor delivery needle and a method for treating prostate cancer with vapor therapy is presented. But, the method is not suitable for the treatment of prostate cancer in humans.
3